Abstract
Protein phosphorylation plays a central role in cellular processes. Recently, a considerable interest in the development of inhibitors of protein kinase has been taken. Mitogen activated protein kinases (MAPKs), a group of Ser/Thr protein kinases, are activated by a wide spectrum of extracellular stimuli. Extensive literature reports have indicated the key role of these kinases in inflammatory processes and in immune response. This review outlines relevant aspects on the development of MAPK inhibitors that could form the molecular basis for a new class of anti-inflammatory and immunoregulatory agents. Particular focus is given to their role in regulating the dysfunction of innate immunity. Also, concepts as docking interactions, participation of scaffold proteins in MAPK cascades and its importance in the design of more specific inhibitors are discussed.
Keywords: immune response, mapk, tlr, mapk inhibitor, inflammatory process, cytokine
Current Enzyme Inhibition
Title: Translating MAPK Inhibitors To Anti-Inflammatory Compounds
Volume: 1 Issue: 1
Author(s): C. Ropert
Affiliation:
Keywords: immune response, mapk, tlr, mapk inhibitor, inflammatory process, cytokine
Abstract: Protein phosphorylation plays a central role in cellular processes. Recently, a considerable interest in the development of inhibitors of protein kinase has been taken. Mitogen activated protein kinases (MAPKs), a group of Ser/Thr protein kinases, are activated by a wide spectrum of extracellular stimuli. Extensive literature reports have indicated the key role of these kinases in inflammatory processes and in immune response. This review outlines relevant aspects on the development of MAPK inhibitors that could form the molecular basis for a new class of anti-inflammatory and immunoregulatory agents. Particular focus is given to their role in regulating the dysfunction of innate immunity. Also, concepts as docking interactions, participation of scaffold proteins in MAPK cascades and its importance in the design of more specific inhibitors are discussed.
Export Options
About this article
Cite this article as:
Ropert C., Translating MAPK Inhibitors To Anti-Inflammatory Compounds, Current Enzyme Inhibition 2005; 1 (1) . https://dx.doi.org/10.2174/1573408052952685
DOI https://dx.doi.org/10.2174/1573408052952685 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hydrogen Sulfide in Inflammation: Friend or Foe?
Inflammation & Allergy - Drug Targets (Discontinued) Insights into the Regulation of Renal Hemodynamic Function in Diabetic Mellitus
Current Diabetes Reviews Down-regulation of MiR-138-5p Protects Chondrocytes ATDC5 and CHON-001 from IL-1 β-induced Inflammation <I>Via</I> Up-regulating SOX9
Current Pharmaceutical Design Quantitative Structure Activity Relationship Studies of Piperazinyl Phenylalanine Derivatives as VLA-4/VCAM-1 Inhibitors
Medicinal Chemistry Plasmid-Based Expression Technology Using Growth Hormone Releasing Hormone: A Novel Method for Physiologically Stimulating Long-Term Growth Hormone Secretion
Combinatorial Chemistry & High Throughput Screening Synthetic Applications of the Nenitzescu Reaction to Biologically Active 5-Hydroxyindoles
Current Organic Chemistry c-Myc Inhibitor 10074-G5 Induces Murine and Human Hematopoietic Stem and Progenitor Cell Expansion and HDR Modulator Rad51 Expression
Current Cancer Drug Targets Prostaglandin J2 Family and the Cardiovascular System
Current Vascular Pharmacology Fcγ Receptor 1 (CD64), a Target Beyond Cancer
Current Pharmaceutical Design Contribution of Aspartic Proteases in Candida Virulence. Protease Inhibitors against Candida Infections
Current Protein & Peptide Science Chemogenomic Investigation of AP-1 Transcriptional Regulation of LTC4 Synthase Expression
Letters in Drug Design & Discovery Microwave Assisted Organic Synthesis (MAOS) of New Dispacamide A Derivatives Bearing a Thiazolinone Platform, Biological Assays on Inhibition of Protein Kinases and Cell Effects
Current Microwave Chemistry Synthetic Peptides: The Future of Patient Management in Systemic Rheumatic Diseases?
Current Medicinal Chemistry The V-ATPase as a Target for Antifungal Drugs
Current Protein & Peptide Science Development of Peptides as Potential Drugs for Cancer Therapy
Current Pharmaceutical Design Amyloid β -Protein Assembly as a Therapeutic Target of Alzheimers Disease
Current Pharmaceutical Design Cargo-Delivery Platforms for Targeted Delivery of Inhibitor Cargos Against Botulism
Current Topics in Medicinal Chemistry Desensitization Protocol for Rituximab-Induced Serum Sickness
Current Drug Safety Graphical Abstracts:
Current Topics in Medicinal Chemistry High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?
Current Pharmaceutical Design